Delivery Order SPE2DB22D1103-SPE2DB25FTDZ6

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB20D1100|SPE2DB25FY66C, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of 4566176661 JARDIANCE 10 MG TABLET 90S. The contract has a ceiling value of $33,354.48 and is a Firm Fixed Price Delivery Order with an ultimate completion date of October 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical...
This federal contract award, with identification number SPE2DB22D1106|SPE2DB25FDNV4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $38,684.97 fixed-price delivery order is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 4, 2024 and was awarded on December 3, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAHV9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $5,678.67 and a completion date of December 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order contract, which is a firm fixed-price...
This federal contract award, with the ID SPE2DB22D3004|SPE2DB24FQV96, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at $9,378.88, is for the delivery of the pharmaceutical product JARDIANCE 10 MG TABLET 90S. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date for the contract is June 26, 2024. Amerisourcebergen Drug Corp, a subsidiary...
This federal contract award, valued at $21,487.89, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4562841995 - JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and a delivery order contract type, with a period of performance through November 17, 2023. The contract was not designated with a set-aside requirement, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a firm fixed price of $14,365.37 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the sole awardee on this contract, which does not have a set-aside designation. The...
This federal contract award, valued at $6,332.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 17, 2024 and is a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is the...
This federal contract award is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $5,871.96 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of JARDIANCE 10 MG TABLET 90S. The contract, valued at $12,828.67, is a delivery order with a firm fixed price structure. The ultimate completion date for this contract is July 10, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is an experienced supplier of pharmaceuticals and medical supplies to various...
This federal contract award, with an ID of SPE2DB20D2002|SPE2DB25FL10P, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $5,113.64, is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 27, 2024. The contract was...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTDZ6
    Delivery Order

This federal contract award, with an ID of SPE2DB22D1103 and SPE2DB25FTDZ6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566893722 units of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $21,257.39 and is a Firm Fixed Price Delivery Order type contract. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen Drug Corp is a for-profit organization and a major pharmaceutical distributor and healthcare solutions provider, registered in the System for Award Management (SAM.gov). The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/11/25, 11:08 AM